At a glance
- Originator Kyowa Hakko
- Class Antiallergics; Antiasthmatics; Bronchodilators; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 15 Jun 1995 Discontinued-Unspecified phase in Asthma in Japan (Unknown route)
- 28 Mar 1995 No-Development-Reported for Asthma in Japan (Unknown route)